Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Esotropia (PD)</td><td class="align_center">Dose of botulinum toxin (units)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">15∼20</td><td class="align_center">2.5</td></tr><tr><td class="align_left">20∼40</td><td class="align_center">5</td></tr><tr><td class="align_left">40∼60</td><td class="align_center">6</td></tr><tr><td class="align_left">60∼80</td><td class="align_center">7</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Data are the total dosage of botulinum toxin per visit. PD: prism diopters.<br/></div></td></tr></table>

Journal of Ophthalmology

tab1

Table 1

Table 1: Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness 